Mohanad Al‐Obaidi

488 total citations
22 papers, 187 citations indexed

About

Mohanad Al‐Obaidi is a scholar working on Infectious Diseases, Epidemiology and Parasitology. According to data from OpenAlex, Mohanad Al‐Obaidi has authored 22 papers receiving a total of 187 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 14 papers in Epidemiology and 2 papers in Parasitology. Recurrent topics in Mohanad Al‐Obaidi's work include Antifungal resistance and susceptibility (14 papers), Fungal Infections and Studies (12 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). Mohanad Al‐Obaidi is often cited by papers focused on Antifungal resistance and susceptibility (14 papers), Fungal Infections and Studies (12 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). Mohanad Al‐Obaidi collaborates with scholars based in United States, Austria and Canada. Mohanad Al‐Obaidi's co-authors include Luis Ostrosky‐Zeichner, Tirdad T. Zangeneh, Bekir Tanrıöver, Sandra Kurtin, Matthias Egger, Martin Hoenigl, Jeffrey D. Jenks, Lorena García, Tommi Gaines and George R. Thompson and has published in prestigious journals such as PLoS ONE, The American Journal of Medicine and PLoS Pathogens.

In The Last Decade

Mohanad Al‐Obaidi

22 papers receiving 184 citations

Peers

Mohanad Al‐Obaidi
Ashley Howard United States
Ümit Savaşçı Türkiye
Behnaz Khodabakhshi Iran
Reinout Naesens Belgium
Şefika Elmas Bozdemir Türkiye
Asmita Gupte United States
Günther Hsue United States
Kevin A. Grimes United States
Ilduara Pintos Spain
Yasir Ahmed United States
Ashley Howard United States
Mohanad Al‐Obaidi
Citations per year, relative to Mohanad Al‐Obaidi Mohanad Al‐Obaidi (= 1×) peers Ashley Howard

Countries citing papers authored by Mohanad Al‐Obaidi

Since Specialization
Citations

This map shows the geographic impact of Mohanad Al‐Obaidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohanad Al‐Obaidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohanad Al‐Obaidi more than expected).

Fields of papers citing papers by Mohanad Al‐Obaidi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohanad Al‐Obaidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohanad Al‐Obaidi. The network helps show where Mohanad Al‐Obaidi may publish in the future.

Co-authorship network of co-authors of Mohanad Al‐Obaidi

This figure shows the co-authorship network connecting the top 25 collaborators of Mohanad Al‐Obaidi. A scholar is included among the top collaborators of Mohanad Al‐Obaidi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohanad Al‐Obaidi. Mohanad Al‐Obaidi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hussain, Nadeem, et al.. (2024). The performance of bronchoalveolar lavage Aspergillus PCR testing in solid organ transplant recipients with invasive pulmonary aspergillosis. Transplant Infectious Disease. 26(5). e14327–e14327. 1 indexed citations
2.
Scott, Ashley, et al.. (2024). Clinical Characteristics and Mortality Risks Among Patients With Culture-Proven Coccidioidomycosis Who Are Critically Ill: A Multicenter Study in an Endemic Region. Open Forum Infectious Diseases. 11(8). ofae454–ofae454. 1 indexed citations
3.
Scott, Ashley, et al.. (2023). 823. Clinical Outcomes of Coccidioidomycosis in Patients Requiring Intensive Care Unit Hospitalization. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations
4.
Al‐Obaidi, Mohanad, Luis Ostrosky‐Zeichner, & David E. Nix. (2023). Trends of Azole Antifungal Prescription in the United States: Medicare Part D Provider Utilization and Payment Data Analysis. Open Forum Infectious Diseases. 10(8). ofad345–ofad345. 3 indexed citations
5.
Zangeneh, Tirdad T. & Mohanad Al‐Obaidi. (2023). Diagnostic Approach to Coccidioidomycosis in Solid Organ Transplant Recipients. Journal of Fungi. 9(5). 513–513. 5 indexed citations
6.
Jenks, Jeffrey D., Mohanad Al‐Obaidi, Matthias Egger, et al.. (2023). Race and ethnicity: Risk factors for fungal infections?. PLoS Pathogens. 19(1). e1011025–e1011025. 27 indexed citations
7.
Al‐Obaidi, Mohanad, et al.. (2023). The Impact of Nirmatrelvir-Ritonavir in Reducing Hospitalizations Among High-Risk Patients With SARS-CoV-2 During the Omicron Predominant Era. The American Journal of Medicine. 136(6). 577–584. 7 indexed citations
8.
Erol, Halil, Mohanad Al‐Obaidi, Tirdad T. Zangeneh, et al.. (2023). Lack of effectiveness of Bebtelovimab monoclonal antibody among high-risk patients with SARS-Cov-2 Omicron during BA.2, BA.2.12.1 and BA.5 subvariants dominated era. PLoS ONE. 18(4). e0279326–e0279326. 9 indexed citations
9.
Zangeneh, Tirdad T., William Lainhart, Nathan P. Wiederhold, & Mohanad Al‐Obaidi. (2023). Coccidioides species antifungal susceptibility testing: Experience from a large healthcare system in the endemic region. Medical Mycology. 61(10). 1 indexed citations
10.
Al‐Obaidi, Mohanad, et al.. (2023). Effectiveness of Casirivimab-Imdevimab and Sotrovimab Monoclonal Antibody Treatment among High-Risk Patients with Sars-Cov-2 Infection: A Real-World Experience. Archives of Clinical and Biomedical Research. 7(3). 1 indexed citations
11.
Al‐Obaidi, Mohanad, et al.. (2022). The Prevention of COVID-19 in High-Risk Patients Using Tixagevimab–Cilgavimab (Evusheld): Real-World Experience at a Large Academic Center. The American Journal of Medicine. 136(1). 96–99. 27 indexed citations
12.
Al‐Obaidi, Mohanad, Saman Nematollahi, Tirdad T. Zangeneh, et al.. (2022). Effectiveness of Casirivimab-Imdevimab Monoclonal Antibody Treatment Among High-Risk Patients With Severe Acute Respiratory Syndrome Coronavirus 2 B.1.617.2 (Delta Variant) Infection. Open Forum Infectious Diseases. 9(7). ofac186–ofac186. 10 indexed citations
13.
Al‐Obaidi, Mohanad, et al.. (2022). The Utility of (1→3)-β-D-Glucan Testing in the Diagnosis of Coccidioidomycosis in Hospitalized Immunocompromised Patients. Journal of Fungi. 8(8). 768–768. 6 indexed citations
14.
Zangeneh, Tirdad T., et al.. (2022). What's Abuzz? Encephalopathy in a Transplant Recipient. A4221–A4221. 1 indexed citations
15.
Al‐Obaidi, Mohanad, et al.. (2021). A Comparative Analysis of Mucormycosis in Immunosuppressed Hosts Including Patients with Uncontrolled Diabetes in the Southwest United States. The American Journal of Medicine. 134(9). 1155–1159. 4 indexed citations
16.
Al‐Obaidi, Mohanad, et al.. (2020). Perinephric abscess in a renal transplant recipient due to Mycoplasma hominis: Case report and review of the literature. Transplant Infectious Disease. 22(5). e13308–e13308. 8 indexed citations
17.
Márquez, José Luis, et al.. (2020). Pulmonary Mucormycosis in a Heart Transplant Patient. The American Journal of Medicine. 133(9). e524–e525. 4 indexed citations
18.
Al‐Obaidi, Mohanad, Rodrigo Hasbun, Karen J. Vigil, et al.. (2019). Seroprevalence of Strongyloides stercoralis and Evaluation of Universal Screening in Kidney Transplant Candidates: A Single-Center Experience in Houston (2012–2017). Open Forum Infectious Diseases. 6(7). 18 indexed citations
19.
Al‐Obaidi, Mohanad, Pamela Younes, & Luis Ostrosky‐Zeichner. (2018). Post-exposure prophylaxis with isavuconazole after occupational exposure to Rhizopus. Oxford Medical Case Reports. 2018(10). omy062–omy062. 3 indexed citations
20.
Ostrosky‐Zeichner, Luis & Mohanad Al‐Obaidi. (2017). Invasive Fungal Infections in the Intensive Care Unit. Infectious Disease Clinics of North America. 31(3). 475–487. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ashley Howard Breakdown of academic impact, for papers by Ümit Savaşçı Breakdown of academic impact, for papers by Behnaz Khodabakhshi Breakdown of academic impact, for papers by Reinout Naesens Breakdown of academic impact, for papers by Şefika Elmas Bozdemir Breakdown of academic impact, for papers by Asmita Gupte Breakdown of academic impact, for papers by Günther Hsue Breakdown of academic impact, for papers by Kevin A. Grimes Breakdown of academic impact, for papers by Ilduara Pintos Breakdown of academic impact, for papers by Yasir Ahmed
Rankless by CCL
2026